Sonoma BioTherapeutics seattle-based company leading the development of adoptive Treg therapies cell for autoimmune. Sonoma BioTherapeutics is backed by investors that include ARCH Venture Partners, 8VC, Milky Way Ventures, and Lyell Immunopharma and is headquartered in South San Francisco.